According to the

New York Times

, the US drug agency (FDA) could authorize as early as Wednesday, the "mixture" of anti-covid vaccines for the boosters.

Be careful, we are not talking here about grub between the different doses, but to use for the booster, an anti-Covid vaccine different from the one used initially for immunization.

A mix, already possible in many countries.

While it is also due to announce its decision on the authorization of booster doses for Moderna and Johnson & Johnson vaccines, the FDA may however recommend giving preference to the injection of a dose of the same vaccine whenever possible. , according to sources cited by the American press.

For the time being, only a booster of Pfizer's vaccine is authorized in the country for certain categories of populations at risk.

Recommended recalls for Moderna and Johnson & Johnson

Such an announcement from health authorities is likely to be of particular interest to people who have received the single-dose vaccine from Johnson & Johnson, or some 15 million Americans.

The information comes after the publication last week of preliminary results from a study conducted in the United States, suggesting that people who have received the "J & J" vaccine may benefit from receiving a booster dose of one. different vaccine, messenger RNA, in order to take advantage of an even greater increase in their antibody levels.

An FDA advisory committee last week recommended authorization of a booster dose of Johnson & Johnson for all people 18 and over, and Moderna for certain categories of the population at risk, including the elderly. .

Once the FDA's decision is announced, a committee of experts from the Centers for Disease Prevention and Control (CDC) will meet on Thursday to in turn review the data supporting the principle of these booster doses, before the agency does not publish its precise recommendations for these injections, intended for healthcare professionals administering them.

Health

France is advancing its seasonal flu vaccination campaign to couple it with the recall against Covid-19

Health

Coronavirus: Why has no new variant emerged for months?

  • Moderna

  • Pfizer-BioNTech

  • Covid 19

  • epidemic

  • Coronavirus

  • Vaccine

  • United States

  • Anti-covid vaccine

  • Health